← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2010Last known activity
Jun 30, 2022
Acquired by Elicio Therapeutics on Jan 17, 2023
Timeline
1990s
- Jun 1, 1998
Angion Biomedica Corp— Founded
2020s
- Jan 17, 2023
Elicio Therapeutics— Acquired By
Drugs by trial phase (4 distinct, 12 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT05387785Lead sponsorPhase 1Jun 30, 2022
- NCT04939116Study directorPhase 2Oct 29, 2021
- NCT04939116Lead sponsorPhase 2Oct 29, 2021
- NCT04958187Lead sponsorPhase 1Jul 31, 2021
- NCT04898907Lead sponsorPhase 1Jun 30, 2021
- NCT04931524Lead sponsorPhase 1May 21, 2021
- NCT04459676Lead sponsorPhase 2Jul 31, 2020
- NCT04459676Study directorPhase 2Jul 31, 2020
- NCT04196179Lead sponsorPhase 1Dec 31, 2019
- NCT04196179Study directorPhase 1Dec 31, 2019
- NCT02771509Lead sponsorPhase 2Dec 1, 2016
- NCT02474667Lead sponsorPhase 3Jan 1, 2016
- NCT01539590Lead sponsorPhase 2Jul 1, 2012
- NCT01561599Lead sponsorPhase 2Aug 1, 2011
- NCT01286727Lead sponsorPhase 2Feb 1, 2010
Details
- Founded
- Uniondale, NY, US Jun 1, 1998
- Last known activity
- Jun 30, 2022